Featured
Status
Health Topics
- Analytical, Diagnostic and Therapeutic Techniques and Equipment40 See more
- Anthropology, Education, Sociology and Social Phenomena4 See more
-
Chemicals and Drugs400
See more
- Amino Acids, Peptides, and Proteins 103
- Biological Factors 25
- Biomedical and Dental Materials 1
- Carbohydrates 16
- Chemical Actions and Uses 63
- Complex Mixtures 32
- Enzymes and Coenzymes 11
- Heterocyclic Compounds 130
- Hormones, Hormone Substitutes, and Hormone Antagonists 31
- Inorganic Chemicals 47
- Lipids 12
- Macromolecular Substances 2
- Nucleic Acids, Nucleotides, and Nucleosides 24
- Organic Chemicals 202
- Pharmaceutical Preparations 10
- Polycyclic Compounds 62
-
Diseases887
See more
- Animal Diseases 1
- Bacterial Infections and Mycoses 65
- Cardiovascular Diseases 92
- Chemically-Induced Disorders 38
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 125
- Digestive System Diseases 89
- Endocrine System Diseases 73
- Eye Diseases 16
- Female Urogenital Diseases and Pregnancy Complications 95
- Hemic and Lymphatic Diseases 117
- Immune System Diseases 126
- Male Urogenital Diseases 78
- Musculoskeletal Diseases 43
- Neoplasms 215
- Nervous System Diseases 147
- Nutritional and Metabolic Diseases 121
- Occupational Diseases 4
- Otorhinolaryngologic Diseases 20
- Parasitic Diseases 13
- Pathological Conditions, Signs and Symptoms 294
- Respiratory Tract Diseases 45
- Skin and Connective Tissue Diseases 40
- Stomatognathic Diseases 17
- Virus Diseases 68
- Wounds and Injuries 30
- Health Care7 See more
-
Phenomena and Processes58
See more
- Psychiatry and Psychology133 See more
- Technology, Industry, Agriculture7 See more
Search Clinical Trials
Completed
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs) (External Link)
Ten to sixty ml (2-12 teaspoons) of blood will be collected from the patient which we use to grow the T cells. These T cells are then stimulated with EBV …
Baylor Role:
Lead Sponsor
Unknown Status
Study of Treatment and Metabolism in Patients With Urea Cycle Disorders (External Link)
PROTOCOL OUTLINE: This protocol involves 2 clinical studies. Part A is a metabolic study of glutamine conversion to urea at different levels of protein intake, while on and off medications. …
Baylor Role:
Collaborator
Completed
Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy (External Link)
Tumor cells from subjects with high-risk neuroblastoma will be obtained at the time of presentation and initial diagnosis, during routine surveillance of bone marrow disease status, or at the time …
Unknown Status
Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion (External Link)
PROTOCOL OUTLINE: Patients are assigned to one of 6 study groups. Patients receive infusions of stable isotope tracers: [15N]urea IV beginning at -12 hours and continuing over 22 hours to …
Baylor Role:
Collaborator
Completed
Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes (External Link)
PROTOCOL OUTLINE: Patients undergo clinical, cytogenetic, and molecular studies. These include radiographic, neurologic, developmental, and 24 hour sleep studies, ophthalmologic, otolaryngologic, speech and language, and audiologic exams, echocardiogram, and renal …
Baylor Role:
Collaborator
Completed
Stem Cell Transplant to Treat Patients With Systemic Sclerosis (External Link)
Before the transplant the research participant will receive daily G-CSF (Neupogen) for 5-6 days. This medication will help to stimulate the production of white blood cells (WBC) that will be …
Baylor Role:
Lead Sponsor
Completed
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine (External Link)
Before starting in the treatment part of this study, leukemia cells and skin fibroblasts will be collected from the patient - called "procurement" - to allow us to make the …
Baylor Role:
Lead Sponsor
Completed
High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis (External Link)
To participate in this study, patients will need to have a central line (a thin plastic catheter or tube that is placed during surgery into one of the large veins …
Baylor Role:
Lead Sponsor
Completed
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program (External Link)
This study was conducted in three phases. The first phase spanned from 1998-2003 (PubMed ID:14706961; PubMed ID: 12915495) and the second phase spanned from 2003-2007 (PubMedID: 18401289; PubMed ID: 17698577). …
Baylor Role:
Lead Sponsor
Withdrawn
Quantitative and Qualitative Changes in Neural Efferent Receptors (External Link)
Twenty-five (25) spinal cord injury patients, as part of their annual cystoscopic screening for squamous cell carcinoma, will be included in this study. Approximately twenty-five (25) control patients without spinal …
Baylor Role:
Lead Sponsor